Eli Lilly and Company News Headlines

LLY 
$62.84
*  
0.31
0.5%
Get LLY Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

A Phase III Failure At Eli Lilly - Yes, Again
9/27/2013 10:59:00 AM - Seeking Alpha

CV Study Update on NVO's Victoza - Analyst Blog
9/26/2013 5:30:01 PM - Zacks.com

Healthcare Stocks Turning Positive; Lilly Sinks More Than 3% After Drug Candidate Fails in Breast-Cancer Study
9/26/2013 1:58:35 PM - MT Newswires

Sector Update: Healthcare
9/26/2013 1:52:48 PM - MT Newswires

Clovis Sinks on Lack of Buyer Interest - Analyst Blog
9/26/2013 11:33:44 AM - Zacks.com

Update on Glaxo's Portfolio - Analyst Blog
9/26/2013 11:33:30 AM - Zacks.com

Pre-Market Most Active for Sep 26, 2013 : FLOW, JCP, FB, HTZ, LLY, TOT, ALU, BUD, DRYS, ARCC, BBRY, MSFT
9/26/2013 8:39:58 AM - NASDAQ.com News

Sector Update: Healthcare Shares Mixed Pre-Market; Eli Lilly Down on Phase 3 Study Results
9/26/2013 8:37:57 AM - MT Newswires

Sector Update: Healthcare
9/26/2013 8:34:33 AM - MT Newswires

More Data on Novo Nordisk's Tresiba - Analyst Blog
9/25/2013 5:10:01 PM - Zacks.com

AbbVie in another Deal with Galapagos - Analyst Blog
9/25/2013 11:18:02 AM - Zacks.com

Kelly Close: State Of Diabetes Treatment, Companies In The Sector And Challenges Patients Face
9/24/2013 6:51:00 PM - Seeking Alpha

Bayer's Xarelto Holds Promise - Analyst Blog
9/24/2013 5:10:01 PM - Zacks.com

China Biotech In Review: Novartis Has A Novel Scandal Potentially Brewing
9/22/2013 5:19:00 AM - Seeking Alpha

Acadia Stock Report: Business Overview And Revenue Projection
9/20/2013 3:50:00 PM - Seeking Alpha

Is Biodel A Buy Or Sell?
9/19/2013 4:40:00 PM - Seeking Alpha

Eli Lilly And Merck: A Pipeline Of Success?
9/16/2013 3:57:00 PM - Seeking Alpha

Celgene: FDA Approvals Shining The Biopharma Stock
9/16/2013 11:36:00 AM - Seeking Alpha

Lixisenatide NDA Withdrawn by Sanofi - Analyst Blog
9/13/2013 10:58:15 AM - Zacks.com

Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
9/12/2013 10:55:00 AM - Seeking Alpha

Will The Pipeline Deliver For Eli Lilly?
9/12/2013 9:07:00 AM - Seeking Alpha

Data on Biodel's BIOD-123 - Analyst Blog
9/10/2013 5:58:09 PM - Zacks.com

FDA Expands Celgene's Abraxane Label - Analyst Blog
9/9/2013 4:57:31 PM - Zacks.com

Seems Like Old Times
9/6/2013 3:35:00 PM - Seeking Alpha

Positive Data on Takeda's AlogliptIn - Analyst Blog
9/3/2013 4:35:01 PM - Zacks.com